These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9859691)

  • 21. It never hurts to check. Taking the time to read a label benefited this migraine sufferer.
    Lilley LL; Guanci R
    Am J Nurs; 1998 Jun; 98(6):14. PubMed ID: 9629078
    [No Abstract]   [Full Text] [Related]  

  • 22. Zolmitriptan: new product. Similar to sumatriptan.
    Prescrire Int; 1999 Apr; 8(40):41-3. PubMed ID: 10848058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine.
    Gallagher RM; Dennish G; Spierings EL; Chitra R
    Headache; 2000 Feb; 40(2):119-28. PubMed ID: 10759911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sumatriptan and zolmitriptan.
    Nurs Times; 2005 Sep 27-Oct 3; 101(39):31. PubMed ID: 16218117
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen.
    Evers S; Rahmann A; Kraemer C; Kurlemann G; Debus O; Husstedt IW; Frese A
    Neurology; 2006 Aug; 67(3):497-9. PubMed ID: 16775229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rational migraine management: optimising treatment with the triptans.
    Millson DS
    Funct Neurol; 2000; 15 Suppl 3():182-91. PubMed ID: 11200789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 311C90: long-term efficacy and tolerability profile for the acute treatment of migraine. International 311C90 Long-Term Study Group.
    Zagami AS
    Neurology; 1997 Mar; 48(3 Suppl 3):S25-8. PubMed ID: 9071267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zolmitriptan provides effective migraine relief in adolescents.
    Linder SL; Dowson AJ
    Int J Clin Pract; 2000 Sep; 54(7):466-9. PubMed ID: 11070573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the efficacy of migraine therapy.
    Chawluk JB
    Postgrad Med; 2000 Sep; 108(3 Suppl):16-21. PubMed ID: 19667526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group.
    Rapoport AM; Ramadan NM; Adelman JU; Mathew NT; Elkind AH; Kudrow DB; Earl NL
    Neurology; 1997 Nov; 49(5):1210-8. PubMed ID: 9371896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient preference for triptan formulations: a prospective study with zolmitriptan.
    Dowson A; Bundy M; Salt R; Kilminster S
    Headache; 2007 Sep; 47(8):1144-51. PubMed ID: 17883519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.
    Martin GR
    Cephalalgia; 1997 Oct; 17 Suppl 18():4-14. PubMed ID: 9399012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute management of migraine: triptans and beyond.
    Diener HC; Limmroth V
    Curr Opin Neurol; 1999 Jun; 12(3):261-7. PubMed ID: 10499171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons.
    Gerth WC; McCarroll KA; Santanello NC; Vandormael K; Zhang Q; Mannix LK
    Int J Clin Pract; 2001 Oct; 55(8):552-6. PubMed ID: 11695077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral migraine treatment approved.
    Nurse Pract; 1998 Jan; 23(1):94. PubMed ID: 9470199
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design.
    Geraud G; Olesen J; Pfaffenrath V; Tfelt-Hansen P; Zupping R; Diener HC; Sweet R
    Cephalalgia; 2000 Feb; 20(1):30-8. PubMed ID: 10817444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P; Landy S; Richardson M; Ames M
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial.
    Mathew NT; Kailasam J; Gentry P; Chernyshev O
    Headache; 2000 Jun; 40(6):464-5. PubMed ID: 10849042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical applications of zolmitriptan (Zomig, 311C90).
    Lipton RB; Stewart WF
    Cephalalgia; 1997 Oct; 17 Suppl 18():53-9. PubMed ID: 9399017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.